Christopher A. Kroeger - 15 Jul 2026 Form 4 Insider Report for MapLight Therapeutics, Inc. (MPLT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Jul 2026, 21:46:47 UTC
Prior SEC filing
18 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kristopher L. Hanson, Attorney-in-Fact

Key filing fact

Christopher A. Kroeger filed Form 4 for MapLight Therapeutics, Inc. (MPLT) on 17 Jul 2026.

Key facts

  • This page summarizes Christopher A. Kroeger's Form 4 filing for MapLight Therapeutics, Inc. (MPLT).
  • 7 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Jul 2026, 21:46.

Change

  • Previous filing in this sequence was filed on 18 May 2026.
  • Current net transaction value: -$5,443,722.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001658918 Primary reporting owner

Kroeger Christopher A.

Relationship
Chief Executive Officer, Director
Address
C/O MAPLIGHT THERAPEUTICS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY
Signature
/s/ Kristopher L. Hanson, Attorney-in-Fact
Signature date
17 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MPLT transaction

Voting Common Stock

Sale

Transaction value
$682,200
Shares
-18,950
Change %
-1.4%
Price
$36.00
Shares after
1,375,144
Date
15 Jul 2026
Ownership
Direct
Footnotes
F1, F2
MPLT transaction

Voting Common Stock

Sale

Transaction value
$1,580,879
Shares
-42,738
Change %
-3.1%
Price
$36.99
Shares after
1,332,406
Date
15 Jul 2026
Ownership
Direct
Footnotes
F1, F3
MPLT transaction

Voting Common Stock

Sale

Transaction value
$3,379
Shares
-90
Change %
-0.01%
Price
$37.54
Shares after
1,332,316
Date
15 Jul 2026
Ownership
Direct
Footnotes
F1
MPLT transaction

Voting Common Stock

Sale

Transaction value
$1,491,178
Shares
-40,899
Change %
-3.1%
Price
$36.46
Shares after
1,291,417
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1, F4
MPLT transaction

Voting Common Stock

Sale

Transaction value
$1,046,671
Shares
-28,091
Change %
-2.2%
Price
$37.26
Shares after
1,263,326
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1, F5
MPLT transaction

Voting Common Stock

Sale

Transaction value
$3,492
Shares
-92
Change %
-0.01%
Price
$37.96
Shares after
1,263,234
Date
16 Jul 2026
Ownership
Direct
Footnotes
F1
MPLT transaction

Voting Common Stock

Sale

Transaction value
$635,924
Shares
-16,779
Change %
-1.3%
Price
$37.90
Shares after
1,246,455
Date
17 Jul 2026
Ownership
Direct
Footnotes
F1, F6
MPLT holding

Voting Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
101,190
Date
15 Jul 2026
Ownership
See footnote
Footnotes
F7
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary sale by the Reporting Person.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.5338 to $36.5273 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F3

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.53 to $37.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F4

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.9075 to $36.9013 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F5

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.9082 to $37.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F6

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.49 to $37.925 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Footnote F7

The shares are held by the C&M Kroeger Nominee Trust, of which the Reporting Person is co-trustee with his spouse and has voting and dispositive power.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .